Completed PHASE2 INTERVENTIONAL 1-arm NCT01163812

Clinical Trial for Laparoscopic D2 Gastrectomy (NCC181)

A Phase-II Clinical Trial of Laparoscopy-Assisted Distal Gastrectomy With D2 Lymph Node Dissection for Gastric Cancer

Sponsor: National Cancer Center, Korea

Interventions Laparoscopic D2 distal gastrectomy

Updated 6 times since 2017 Last updated: Jul 16, 2010 Started: Apr 30, 2006 Primary completion: Oct 31, 2006 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Gastric Cancer, this trial is completed. The trial is conducted by National Cancer Center, Korea and has accumulated 6 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Center, Korea

Data source: National Cancer Center, Korea

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Goyang, South Korea